Skip to content
Open access · OA via Europe PMC

Testing the Translational Potential of Rapamycin on Healthy Aging

Authors not listed

Innovation in aging · 2025

Abstract

This study examines the translational potential of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) in the context of healthy aging. It was published in Innovation in aging in 2025.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
Canonical
link ↗
Fetched
2026-07-01 MST

Cite this

APA
Anonymous. (2025). Testing the Translational Potential of Rapamycin on Healthy Aging. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC12759609
Vancouver
Anonymous. Testing the Translational Potential of Rapamycin on Healthy Aging. Innovation in aging. 2025.
BibTeX
@article{anon2025Testin, title = {Testing the Translational Potential of Rapamycin on Healthy Aging}, author = {Anonymous}, journal = {Innovation in aging}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings